HTBX - Heat Biologics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Heat Biologics's activity chart (see below) currently has 9 price targets and 11 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 33.33% of the time, taking 300.67 days on average.

Most recent stock forecast was given by MAYANK MAMTANI from B. RILEY on 18-Mar-2022. First documented stock forecast 09-Jul-2018.

Best performing analysts who are covering HTBX - Heat Biologics:

James Molloy Jason Mccarthy Mayank Mamtani

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 28-Dec-2020

$8

$10

4 years 8 months 4 days ago
(18-Mar-2022)

0/4 (0%)

$5.37 (204.18%)

Buy Since 09-Jul-2018

$20

4 years 8 months 7 days ago
(15-Mar-2022)

1/2 (50%)

$13.27 (197.18%)

107

Buy Since 06-Mar-2020

$22

5 years 10 months ago
(22-Jan-2021)

1/2 (50%)

$15.11 (219.30%)

795

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is HTBX (Heat Biologics) average time for price targets to be met?

On average it took 301 days for the stock forecasts to be reached, with an average price target met ratio of 33.33%.

Which analyst most recently updated their price target on HTBX (Heat Biologics)?

Mayank Mamtani

Which analyst has the lowest performance score on HTBX (Heat Biologics) with a proven track record?

MAYANK MAMTANI

Which analyst has the most public recommendations on HTBX (Heat Biologics)?

Mayank Mamtani works at B. RILEY and has 5 price targets and 4 ratings on HTBX

Which analyst is the currently most bullish on HTBX (Heat Biologics)?

Jason Mccarthy with the highest potential upside of $19.45

Which analyst is the currently most reserved on HTBX (Heat Biologics)?

James Molloy with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?